Powering High-Value Decisions with
Precision Insights
Since 1998, Kalorama, part of Science and Medicine Group, has been a trusted leader in life science market intelligence for top IVD manufacturers, investors, and healthcare stakeholders. While others spread thin across multiple verticals, we go deep – specializing in sectors like IVD, medical devices, biotechnology, and pharmaceuticals. Our goal is simple: turn data into clear actionable insights so business can make smarter decisions, identify growth opportunities, and stay ahead of change.
Industries We Serve
Healthcare • Biotechnology • Laboratory Diagnostics • Medical Devices • Pharmaceuticals
Our Solutions
Explore our comprehensive suite of solutions, designed to drive your success. Why? Because when you succeed, science and medicine move forward.
Latest Resource
Latest CDC Findings: A Wake‑Up Call for the $1.3 Billion Global Sepsis Diagnostics Market
April 6, 2026
Daniel Granderson
Kalorama Information estimates that the global market for sepsis diagnostics reached approximately $1.3 billion in 2025, reflecting the enormous clinical and economic weight sepsis places on global healthcare. Yet despite steady growth and widespread use of diagnostic tools, sepsis is persistently one of the most difficult conditions to identify and manage. That reality is underscored by recent…
Latest Market Reports
Our syndicated reports are vital tools for companies aiming to develop and implement effective market strategies. View our latest reports below.
In Vitro Diagnostics Business Outlook, 2026
March 30, 2026
The in vitro diagnostics (IVD) industry is a cornerstone of modern healthcare, empowering clinicians to detect disease, monitor health conditions, and guide treatment decisions with precision. As healthcare continues to evolve—driven by rising rates of chronic conditions such as diabetes and cardiovascular disease, along with ongoing and emerging infectious threats—the IVD market is…
Price range: $7,000.00 through $10,000.00
Worldwide IVD Panel-Based Testing: Respiratory/Non-Respiratory, 2020-2030
March 24, 2026
The global market for respiratory and non-respiratory IVD panel-based testing is undergoing continued structural evolution. Panel-based tests allow for the simultaneous detection of multiple pathogens and or resistance markers from a single specimen, supporting efficient workflows, faster time to results, and greater diagnostic confidence. Market growth is increasingly driven by broader clinical adoption and expanding…
Price range: $5,600.00 through $8,000.00
Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 11th Edition (2025 to 2030)
March 13, 2026
Molecular point-of-care testing continues to reshape diagnostic workflows by bringing the accuracy of molecular methods closer to the patient. In Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 11th Edition (2025 to 2030), Kalorama Information examines a market that has matured significantly over the past decade while remaining dynamic. Distinctions between true point-of-care and near patient…
Price range: $5,775.00 through $8,250.00
Our Customers
